Journal
CYTOKINE & GROWTH FACTOR REVIEWS
Volume 12, Issue 4, Pages 361-373Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S1359-6101(01)00012-0
Keywords
RET proto-oncogene; glial cell line-derived neurotrophic factor; papillary thyroid carcinoma; multiple endocrine neoplasia 2; Hirschsprung's disease
Categories
Ask authors/readers for more resources
Glial cell line-derived neurotrophic factor (GDNF) and related molecules, neurturin, artemin and persephin, signal through a unique multicomponent receptor system consisting of RET tyrosine kinase and glycosyl-phosphatidylinositol-anchored coreceptor (GFR alpha1-4). These neurotrophic factors promote the survival of various neurons including peripheral autonomic and sensory neurons as well as central motor and dopamine neurons, and have been expected as therapeutic agents for neurodegenerative diseases. In addition, it turned out that the GDNF/RET signaling plays a crucial role in renal development and regulation of spermatogonia differentiation. RET mutations cause several human diseases such as papillary thyroid carcinoma, multiple endocrine neoplasia types 2A and 2B, and Hirschsprung's disease. The mutations resulted in RET activation or inactivation by various mechanisms and the biological properties of mutant proteins appeared to be correlated with disease phenotypes. The signaling pathways activated by GDNF or mutant RET are being extensively investigated to understand the molecular mechanisms of disease development and the physiological roles of the GDNF family ligands. (C) 2001 Elsevier Science Ltd, All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available